| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/25/2006 | EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 01/25/2006 | EP0914158B2 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 01/25/2006 | EP0869788B1 Compositions for the treatment of renal failure, comprising l-carnosine |
| 01/25/2006 | EP0759781B1 Compositions for treating and preventing atherosclerosis |
| 01/25/2006 | CN1726393A Compounds and methods for detection of carcinomas and their precursor lesions |
| 01/25/2006 | CN1726287A Method of distinguishing drug-resistance of hepatitis b virus |
| 01/25/2006 | CN1726284A Protein modification |
| 01/25/2006 | CN1726283A Production of multimeric fusion proteins using a C4BP scaffold |
| 01/25/2006 | CN1726046A Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 01/25/2006 | CN1726045A Freeze-dried interferon-gamma composition for transpulmonary administration and inhalation system therefor |
| 01/25/2006 | CN1726044A Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| 01/25/2006 | CN1726041A Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) with an inhibitor of cytochrome p450, such as protease inhibitors |
| 01/25/2006 | CN1726014A Novel dry powder inhalation system for transpulmonary administration |
| 01/25/2006 | CN1725991A Delivery of peroxide-generating enzymes to the vaginal tract |
| 01/25/2006 | CN1724687A Relativity of proangiotension transferase 2 gene and prinary hypertension |
| 01/25/2006 | CN1724682A Cordyceps polypeptide product and its preparation method and application |
| 01/25/2006 | CN1724666A Immune tbid gene and its coded protein and application |
| 01/25/2006 | CN1724566A Antibacterial, anti indextoxin allesteric peptide molecular and its synthesis method |
| 01/25/2006 | CN1724563A Exendin 4 polypeptide segment |
| 01/25/2006 | CN1724561A Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application |
| 01/25/2006 | CN1724558A Series peptide for inhibiting growth of cancer cell and bone marrow karyocyte and its application |
| 01/25/2006 | CN1724067A Application of lumbricus plasmin component for anti-tumour |
| 01/25/2006 | CN1724066A Controlled release composition and method of producing the same |
| 01/25/2006 | CN1723921A Extractive of clam glycopeptide, and its prepn. method |
| 01/25/2006 | CN1238522C Interleukin-2 and test method of its gene in drug-stopping application |
| 01/25/2006 | CN1238382C Molt-inhibiting hormone-1 protein of mitten crab |
| 01/25/2006 | CN1238379C New osteoclast formation inhibiting factor and its coding sequence and use |
| 01/25/2006 | CN1238378C An antibiotic peptide and its coded sequence and use |
| 01/25/2006 | CN1238377C Acidic antibacterial peptides and gene as well as its application in pharmacy |
| 01/25/2006 | CN1238376C Mutatant protein of human stem cell growth factor as well as its preparing method and medicine composition |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/25/2006 | CN1238054C Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and its uses |
| 01/25/2006 | CN1238053C Medicine composition containing alfa-interferon , lamivudine and adefovir |
| 01/25/2006 | CN1238052C Obtaining of cell growth inhibiting polypeptide and its usage |
| 01/25/2006 | CN1237980C Anti virus health care product extracted from sea weed and its preparation method |
| 01/25/2006 | CN1237968C Methods for inhibiting proliferation and inducing apoptosis of cancer cells |
| 01/24/2006 | US6989452 Anticancer agents |
| 01/24/2006 | US6989441 Nucleotide sequences coding transport protein for use in the treatment of vision defcets, liver, cardiovascular, nervous system and cell proliferation disorders |
| 01/24/2006 | US6989437 Exposing alpha -keratin molecules comprising reactive pendant groups to silicone crosslinking agent to form covalent interprotein crosslinks |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989434 cationic lipids containing stigmasterol, ergosterol and cholic acid groups; for transfecting a cell |
| 01/24/2006 | US6989377 Treating vitamin D responsive diseases |
| 01/24/2006 | US6989375 Contacting a target cell with DNA-damaging agent; removing DNA-damaging agent from target cell; transferring transgene into target cell between about 1-3 days after removing DNA-damaging agent |
| 01/24/2006 | US6989374 Gene therapy for cardiomyopathy |
| 01/24/2006 | US6989373 By injecting a biocompatible solution, with a given intrinsic viscosity, similar to a fatty acid mixture normally present in a healthy fat pad; treating heel pain |
| 01/24/2006 | US6989371 Bombesin analogs for treatment of cancer |
| 01/24/2006 | US6989370 bacteriocin produced by a Paenibacillus polymyxa strain having the identifying characteristics of strain NRRL B-30507; use in control of disease in animals, especially poultry |
| 01/24/2006 | US6989369 Kunitz domain peptides |
| 01/24/2006 | US6989368 Use of calmodulin to promote bone regeneration |
| 01/24/2006 | US6989367 OBG3 globular head and uses thereof |
| 01/24/2006 | US6989366 Exendins, exendin agonists, and methods for their use |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989364 treatment extends to all stages of progression of cardiac hypertrophy, with or without structural damage of the heart muscle, regardless of the underlying cardiac disorder |
| 01/24/2006 | US6989363 Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| 01/24/2006 | US6989270 Using polyamide nucleic acid oligomers to engender a biological response |
| 01/24/2006 | US6989268 Comprises deletion in adenovirus-2 early region 1A gene; for expression of a protein effective in regulating the cell cycle (such as p53, mitosin, or thymidine kinase suicide genes); tumor suppressor genes/proteins |
| 01/24/2006 | US6989262 Plasmin variants and uses thereof |
| 01/24/2006 | US6989261 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989255 for protection against staphylococcus infection; fusion proteins |
| 01/24/2006 | US6989244 Method for screening compounds inhibiting signal transduction through inflammatory cytokines |
| 01/24/2006 | US6989232 Methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins |
| 01/24/2006 | US6989163 Arrangement to enhance a woman's sexual sensitivity by a combination of phytoestrogens, L-arginine and menthol |
| 01/24/2006 | US6989148 Treatment of diabetes |
| 01/24/2006 | US6989147 Tumor necrosis factor receptor protein for use in the treatment of arthritis |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6989144 Glycoprotein VI antibodies and uses thereof |
| 01/24/2006 | US6989143 Depletion method of blood plasma ascorbate |
| 01/24/2006 | US6988446 Purified nitric oxide synthase |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/24/2006 | CA2339353C Fast dissolving orally consumable films |
| 01/24/2006 | CA2186042C Cosmetic or dermopharmaceutical patch containing in an anhydrous polymeric matrice at least one active component, especially unstable in oxidative media, and at least one water absorbing agent |
| 01/23/2006 | WO2007046781A1 Furin inhibitors |
| 01/23/2006 | CA2586086A1 Furin inhibitors |
| 01/21/2006 | CA2512515A1 Super-antigen fusion proteins and the use thereof |
| 01/19/2006 | WO2006007565A2 Cd40 variants skipping exon 5 |
| 01/19/2006 | WO2006007560A2 Targeted protein replacement for the treatment of lysosomal storage disorders |
| 01/19/2006 | WO2006007529A2 Immunosuppressive exosomes |
| 01/19/2006 | WO2006007509A2 Epidermal growth factor receptor antagonists and methods of use |
| 01/19/2006 | WO2006007448A2 Pharmaceutical co-crystal compositions and related methods of use |
| 01/19/2006 | WO2006007417A2 Repair of tympanic membrane perforation |
| 01/19/2006 | WO2006007412A2 Peptide yy formulations having increased stability and resistance to microbial agents |
| 01/19/2006 | WO2006007411A2 Methods and compositions for modulating bax-mediated apoptosis |
| 01/19/2006 | WO2006007375A2 Use of bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes |
| 01/19/2006 | WO2006007332A1 Oral delivery of peptide pharmaceutical compositions |
| 01/19/2006 | WO2006006674A1 Pth-containing preparation for transmucosal administration |
| 01/19/2006 | WO2006006172A2 Use of anti-amyloid agents for treating and typing pathogen infections |
| 01/19/2006 | WO2006006167A2 Compositions and methods for dermatological wound healing |
| 01/19/2006 | WO2006006165A2 Use of erythropoietin for enhancing immune responses and for treatment of lymphoproliferative disorders |
| 01/19/2006 | WO2006006074A2 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 01/19/2006 | WO2006005912A2 Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas |
| 01/19/2006 | WO2006005910A2 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
| 01/19/2006 | WO2006005707A2 Method for preventing and treating alzheimer´s disease |
| 01/19/2006 | WO2006005610A1 Use of a combination of cyclosporine and pegylated interferon for treating hepatitis c (hcv) |
| 01/19/2006 | WO2006005592A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005591A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005588A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005587A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005586A2 New polypeptide species specific to cerebrospinal fluid |
| 01/19/2006 | WO2006005584A1 Polypeptide species useful for the treatment of neurological disorders |